UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Date of Report (Date of earliest event reported): May 4, 2004
PHARMACOPEIA, INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
0-27118 |
|
33-0557266 |
||
|
(State
or other jurisdiction of |
|
(Commission |
|
(I.R.S.
Employer |
||
|
|
|
|
|
|
||
|
PO Box 5350, Princeton, New Jersey |
|
|
|
08543-5350 |
||
|
(Address of principal executive offices) |
|
|
|
(Zip Code) |
||
|
|
|
|
|
|
||
|
(609) 452-3600 |
||||||
|
(Registrant’s telephone number, including area code) |
||||||
|
|
|
|
|
|
||
|
December 31, 2003 |
||||||
|
(Former name, former address and former fiscal year, if changed since last report) |
||||||
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
|
Exhibit Number |
|
Description |
|
99.1 |
|
Press Release dated May 4, 2004 |
|
|
|
|
|
99.2 |
|
Transcript of the earnings conference call held May 4, 2004 for the quarter ended March 31, 2004 |
Item 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On May 4, 2004, Pharmacopeia issued a press release announcing the financial results for the quarter ended March 31, 2004. A copy of Pharmacopeia’s press release is furnished as an exhibit to this report.
On May 4, 2004, Pharmacopeia held a conference call in connection with the announcement of its financial results for the quarter ended March 31, 2004. A copy of the transcript of Pharmacopeia’s conference call is furnished as an exhibit to this report.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
PHARMACOPEIA, INC. |
|||
|
|
|
|||
|
|
|
|||
|
|
By: |
|
/s/ Arthur E. Roke, CPA |
|
|
|
Arthur E. Roke, CPA, Vice |
|||
|
|
President and Chief Accounting Officer |
|||
|
|
|
|||
|
|
|
|||
|
Date: May 5, 2004 |
|
|||
2